ReviewTransgenic research2026
CRISPR genome editing in food and feed crops: intellectual property challenges, global accessibility, and the Indian perspective.
Review in Transgenic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The ever-increasing global demand for food and feed, coupled with population growth and climate change, necessitates the development of high-yielding and stress-resilient crops. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has emerged as a transformative genome-editing tool due to its efficiency, precision, and ability to generate targeted genetic modifications. This review highlights recent advances in CRISPR genome editing, including base editing, prime editing, and novel Cas variants, together with emerging approaches such as epigenome editing, mitochondrial genome editing, and hypercompact Cas systems, and their applications in improving crop productivity, stress tolerance, and nutritional quality. In food and feed crops, these applications also include crop-specific priorities such as grain and nutritional quality in food crops and digestibility, forage quality, and mineral bioavailability in feed and forage crops. Particular emphasis is placed on the complex intellectual property (IP) landscape surrounding CRISPR technologies, including patents on editing systems, delivery platforms, and proprietary vectors. These intellectual property barriers can restrict research access, technology transfer, and commercialization, particularly in developing countries. The review further discusses patent limitations, licensing frameworks, and strategies to enhance equitable global access through collaborative approaches such as non-exclusive licensing, humanitarian licensing, indigenous technology development, and international partnerships. Overall, the review underscores the need to balance innovation, intellectual property protection, and global accessibility to ensure that CRISPR-based technologies contribute effectively to worldwide food and feed security and sustainable agriculture.
Indexed as
Identifiers
42867739What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.